Bisphenols as Hormone Disruptors: Health Risks of Exposure 

Bisphenols: One of the most widespread synthetic chemicals on Earth
Bisphenols: One of the most widespread synthetic chemicals on Earth

Table of Contents

Abstract

Bisphenols, including BPA and its structural analogues, are ubiquitous environmental contaminants widely used in plastics and consumer products. Their capacity to mimic or antagonise natural hormones enables them to interact with multiple endocrine receptors, such as ERα/ERβ, GPER, ERRγ, AR, THR, PPARs, GR, and PR, through both genomic and rapid non‑genomic pathways. This multi‑receptor interference produces a broad spectrum of adverse health outcomes, ranging from reproductive and metabolic disorders to neurodevelopmental, immune, and cardiovascular dysfunction. Critical developmental windows, including prenatal and early childhood stages, represent periods of heightened vulnerability, where exposure can program long‑term disease trajectories and even transgenerational effects. Evidence from epidemiological studies and experimental models underscores that bisphenols act as whole‑system disruptors rather than isolated toxicants. Moreover, analogues marketed as “BPA‑free” alternatives (e.g., BPS, BPF, BPAF) frequently demonstrate equal or greater endocrine activity, undermining their presumed safety. Understanding these mechanisms is essential for advancing regulatory frameworks and guiding the design of genuinely safer substitutes to mitigate the population‑level health risks posed by bisphenol contamination.

Introduction: From Molecular Disruption to Clinical Disease

The mechanisms of endocrine disruption described known as hormone receptor binding, mimicry of natural hormones, and interference with multiple signalling pathways, translate into a comprehensive spectrum of adverse health outcomes that span virtually every physiological system [1; 2; 3; 4; 5; 6]. The ability of bisphenols to bind to estrogen receptors (ERα, ERβ, GPER), antagonize androgen receptors (AR), activate PPARγ, and disrupt thyroid hormone signaling creates a cascade of biological effects that manifest as clinical disease [3; 7; 8; 9; 10; 11].

A particularly insidious feature of bisphenol exposure is its impact during critical developmental windows [12; 13; 14; 15; 16]. Exposure during prenatal development, infancy, and childhood, periods when hormonal signals orchestrate fundamental processes of organ development, sexual differentiation, and metabolic programming, can establish disease trajectories that persist across the lifespan [1; 17; 18; 19; 20]. These early exposures may not produce immediate symptoms but instead program vulnerability to conditions that emerge years or decades later, from reproductive disorders in adulthood to metabolic disease in middle age [16; 21; 22; 23].

Evidence from epidemiological studies and experimental models demonstrates that bisphenols act as whole‑system disruptors, rather than toxins with isolated effects [5; 24; 25; 26]. Because sex hormones, thyroid hormones, and metabolic regulators govern processes in nearly every organ, interference with these fundamental signalling systems produces effects that ripple across reproductive health, metabolism, neurodevelopment, immune function, and cardiovascular health [2; 3; 10; 27]. Furthermore, emerging evidence of transgenerational effects—where parental or grandparental exposure affects offspring who were never directly exposed—raises profound questions about the long-term population-level consequences of ubiquitous bisphenol contamination [14; 20].

The following sections organise the documented health risks by physiological system, emphasising the mechanistic links to the receptor pathways discussed previously and highlighting how BPA analogues (BPS, BPF, BPAF) often produce comparable or even more severe effects, undermining the premise that "BPA-free" products offer meaningful safety improvements [6; 11; 16; 28].

Reproductive and Fertility Disorders

As potent xenoestrogens that bind to estrogen receptors (ERα, ERβ, GPER) and antagonize the androgen receptor (AR), bisphenols are heavily implicated in both male and female reproductive dysfunction [1; 4; 6; ; 15; 16]. The disruption of sex hormone signalling during critical periods of reproductive development and function produces effects ranging from infertility and poor gamete quality to structural abnormalities in reproductive organs.

Key Insight: The reproductive effects demonstrate how bisphenols' structural mimicry of sex hormones directly translates into functional impairment of reproductive systems in both sexes. The documented effects of BPS and other analogues on semen parameters and reproductive development underscore that substitution has failed to eliminate reproductive risks. 

Female Reproductive Health

Health Outcome

Key Evidence

Affected Population

Mechanistic Link

Infertility and reduced fecundity

BPA exposure linked to female infertility, interference with follicular development, oocyte quality, and steroidogenesis [3; 5; 9; 13; 14; 16; 19; 29; 30; 31]

Women of reproductive age, particularly those seeking fertility treatment

ER activation disrupts normal hormonal signaling required for follicle maturation and ovulation

Polycystic Ovary Syndrome (PCOS)

Elevated serum BPA levels in women diagnosed with PCOS; neonatal exposure induces PCOS-like phenotype in adult rats [3; 16; 17; 19; 31; 33]

Young women, particularly with early-life exposure

Developmental programming through ER-mediated disruption of hypothalamic-pituitary-ovarian axis

Oocyte and embryo damage

Exposure during in vitro maturation causes spindle abnormalities and chromosome misalignment; reduced estradiol response during IVF; adverse IVF outcomes [14; 16; 19]

Women undergoing assisted reproduction

Direct interference with meiotic spindle formation and hormonal response during follicular maturation

Endometriosis and uterine fibroids

BPA exposure associated with increased risk; impaired decidualization of uterine stromal fibroblasts affecting implantation [12; 18; 19]

Women of reproductive age

ER-mediated promotion of abnormal endometrial tissue growth and proliferation

Diminished ovarian reserve

BPA and BPS/BPF exposure associated with diminished ovarian reserve and premature ovarian insufficiency [19]

Women approaching or in early reproductive years

Accelerated follicular depletion through disrupted ovarian steroidogenesis

Transgenerational effects

Prenatal exposure to BPA and analogues (BPE, BPS) induces transgenerational effects on female reproductive functions in mice [14]

Future generations not directly exposed

Epigenetic programming affecting germline

Male Reproductive Health

Health Outcome

Key Evidence

Affected Population

Mechanistic Link

Impaired fertility and semen quality

Declining male sexual function, poor semen quality (lower sperm count, altered motility/morphology), idiopathic male infertility [3; 6; 8; 10; 15; 16; 19; 26; 32; 34]

Men of reproductive age, particularly those with unexplained infertility

AR antagonism reduces testosterone signaling essential for spermatogenesis; ER activation disrupts hormonal balance

Disrupted steroidogenesis

Impaired testicular steroidogenesis, decreased testosterone production, disrupted insulin signaling in testes [1; 6; 7; 10; 14; 15; 20; 35]

Males exposed during development or adulthood

Interference with Leydig cell function through multiple receptor pathways (ER, AR, GPER)

Testicular damage

Neonatal exposure impairs fertility and Sertoli cell junctional protein expression; apoptosis in male germ cells [7; 10; 15; 16; 20; 35]

Males exposed during critical developmental windows

Developmental disruption of blood-testis barrier and germ cell survival

BPA analogue effects

BPS negatively associated with semen parameters; prenatal exposure to analogues disrupts male reproductive functions; BPAF and F-9-BP induce gonadal injuries in zebrafish [6; 7; 14; 15; 19]

Males exposed to "BPA-free" products

Similar receptor binding profiles produce comparable or worse reproductive toxicity

Metabolic and Cardiovascular Disorders

Bisphenols are strongly linked to metabolic dysfunction through their interference with insulin signalling and promotion of adipogenesis via PPARγ activation [3; 5; 14; 11; 17; 22; 23;]. This classification of bisphenols as obesogens, chemicals that promote obesity and metabolic disease, reflects their ability to fundamentally reprogramme metabolic set points, particularly when exposure occurs during development.

Key Insight: The metabolic effects reveal bisphenols as fundamental disruptors of energy homeostasis. The obesogen effects, combined with direct cardiovascular toxicity, create a dangerous synergy, were metabolic programming leads to cascading health consequences. The documented transgenerational inheritance of cardiac disorders in animal models [20] suggests that parental exposure may predispose offspring to cardiovascular disease, a profoundly concerning finding for population health.

Health Outcome

Key Evidence

Affected Population

Mechanistic Link

Obesity and metabolic syndrome

Increased risk for obesity, metabolic syndrome, adiposity, and "diabesity phenotype" [3; 4; 5; 10; 14; 16; 21; 22; 23; 33]

Children and adults with early-life exposure; general population with chronic exposure

PPARγ activation promotes adipocyte differentiation and lipid accumulation; ER-mediated disruption of energy homeostasis

Type 2 diabetes and insulin resistance

Impaired insulin action in adipocytes, hyperglycemia, disrupted pancreatic β-cell function, insulin resistance contributing to T2DM [2; 3; 7; 11; 21; 23; 27; 30]

Adults with chronic exposure; individuals with developmental exposure showing later-life effects

Direct impairment of insulin signaling pathways; inflammatory cascade activation; β-cell dysfunction

Cardiovascular disease

Adverse cardiovascular outcomes including hypertension, peripheral arterial disease, atherosclerosis, cardiomyopathy, cardiotoxicity [2; 3; 4; 5; 10; 20; 23; 36; 37; 38]

Adults with chronic exposure; offspring of exposed parents (transgenerational cardiac effects observed)

GPER-mediated effects on vascular function; metabolic dysfunction leading to cardiovascular sequelae; direct cardiotoxicity

Dyslipidemia

Hypercholesterolemia in mice; exaggerated hepatic lipid metabolism disorders with BPA and analogues (BPF, BPAF) [6; 7]

Individuals with chronic exposure

PPARγ and liver receptor pathways affecting lipid synthesis and metabolism

Neurodevelopmental and Behavioural Effects

BPA and its substitutes can cross both the placental and blood-brain barriers, leading to nervous system toxicity and behavioural changes [2; 8; 11; 12; 19; 28; 37]. The brain is particularly vulnerable during prenatal and early childhood development when sex hormones and thyroid hormones play critical organisational roles in neural circuit formation.

Key Insight: The neurodevelopmental effects demonstrate that bisphenols are neurotoxicants, not merely endocrine disruptors. The ability to cross the blood-brain barrier and disrupt the organizational effects of hormones during brain development creates vulnerability to cognitive and behavioural problems. The finding that BPS and BPB produce comparable neurotoxicity undermines claims that substitutes are safer for developing brains.

Health Outcome

Key Evidence

Affected Population

Mechanistic Link

Behavioural and cognitive deficits

Prenatal and childhood BPA exposure associated with altered neurobehavioral responses and effects on cognitive function in children [2; 19]

Children with prenatal or early-life exposure

Disruption of sex hormone and thyroid hormone signaling during critical neurodevelopmental windows

Neurotoxicity and memory impairment

Hippocampal neurotoxicity and memory impairment in rats; decreased learning ability through suppression of mitochondrial oxidative phosphorylation in hippocampus [2]

Exposed individuals, particularly during development

Direct neurotoxic effects on hippocampal neurons; mitochondrial dysfunction affecting neuronal energy metabolism

Neuroendocrine disruption

Disruption of HPA (hypothalamic-pituitary-adrenal) axis stress response; altered gene expression in prefrontal cortex [2]

Individuals exposed during developmental periods

ER and GR-mediated disruption of stress axis programming

Effects of BPS and BPB

Neurobehavioral toxic effects in animal models [28; 37]

Populations exposed to "BPA-free" products

Similar blood-brain barrier penetration and receptor binding profiles

Endocrine Gland and Systemic Disruption

Beyond their effects on sex hormones and metabolism, bisphenols interfere with other critical endocrine axes and produce system‑wide disruption of immune function and cancer susceptibility. Their ability to act on multiple hormone receptors means that endocrine glands such as the thyroid, adrenal, and pituitary is also vulnerable to bisphenol exposure. This multi‑axis interference contributes to dysregulation of growth, stress responses, and energy balance, while simultaneously weakening immune surveillance and increasing the risk of hormone‑dependent cancers.

Key Insight: The thyroid disruption is particularly concerning given thyroid hormones' essential roles in metabolism, growth, and brain development. The immune modulation and oxidative stress induction suggest that bisphenols create a pro-inflammatory state that may contribute to numerous chronic diseases. The cancer susceptibility data, especially regarding developmental exposure, indicates that early-life exposure may programme increased cancer risk decades later.

Thyroid Disruption

Health Outcome

Key Evidence

Mechanistic Link

Thyroid hormone signalling interference

BPA, BPS, and BPF interfere with thyroid hormone signalling pathway; higher urinary BPA associated with nodular goitre and papillary thyroid carcinoma [3; 6; 11; 29]

THR (TRα and TRβ) antagonism disrupts thyroid hormone action essential for metabolism, growth, and neurodevelopment

Immune Modulation and Oxidative Stress

Health Outcome

Key Evidence

Mechanistic Link

Immune system dysregulation

Modulation of immune response; developmental exposure affects immune-related diseases [2; 3; 8; 26; 37; 39; 40; 41]

ER-mediated effects on immune cell function; developmental programming of immune system

Oxidative stress and inflammation

Induction of oxidative stress and inflammatory pathways [4; 10; 12; 15; 16; 20; 21; 26; 27; 37]

Disruption of cellular redox balance; activation of inflammatory cascades through multiple receptor pathways

Cancer Susceptibility

Health Outcome

Key Evidence

Mechanistic Link

Altered cancer risk

Developmental BPA exposure implicated in altering susceptibility to breast cancer and prostate cancer [1; 3; 5; 30; 31; 34; 40; 42]

ER-mediated promotion of hormone-sensitive tissue proliferation; developmental reprogramming of cancer susceptibility

Adverse Pregnancy and Developmental Outcomes

Exposure to bisphenols during gestation results in transfer to the foetus and placenta, creating vulnerability during the most sensitive period of development. Such exposures can disrupt placental hormone signalling and nutrient transport, altering the intrauterine environment in ways that impair growth and organogenesis. These early perturbations may set the stage for long‑term developmental disorders, reproductive dysfunction, and metabolic disease later in life.

Key Insight: The pregnancy and developmental effects represent perhaps the most concerning category of bisphenol toxicity. Exposure during these critical windows does not just affect the exposed individual but programmes disease risk across the lifespan and potentially across generations. The disruption of placental function creates a cascade of developmental vulnerabilities that manifest as immediate birth outcomes (preterm birth, altered growth) and latent effects that emerge in childhood, adolescence, or adulthood.

Health Outcome

Key Evidence

Affected Population

Mechanistic Link

Placental and foetal development disruption

Disrupted placental function, hormone secretion, and fetal development; association with preeclampsia [8; 12; 13; 18; 19; 20; 37; 41]

Pregnant women and developing fetuses

ER and GPER-mediated disruption of placental steroidogenesis and vascular function

Adverse birth outcomes

Risks to fetal growth parameters; increased risk of preterm birth [13; 19]

Developing fetuses

Placental insufficiency; disrupted hormonal environment for fetal growth

Disrupted genital development

Prenatal exposure to bisphenol analogues disrupts genital development in male mice [6]

Male fetuses exposed during critical differentiation windows

AR antagonism and ER activation during sexual differentiation

Synthesis: The Whole-Body Burden of Endocrine Disruption

The health risks documented across these physiological systems reveal bisphenols as comprehensive disruptors of human physiology rather than chemicals with isolated toxic effects. The breadth of these effects stems directly from the fundamental mechanisms described in the previous section: when chemicals interfere with hormones that regulate reproduction, metabolism, neurodevelopment, and immune function, virtually no system escapes their influence.

Several themes emerge from this evidence base:

  • Critical windows vulnerability: The most severe and persistent effects occur when exposure happens during prenatal development, infancy, or childhood—periods when hormones orchestrate irreversible developmental programming. These early exposures establish disease trajectories that may not manifest clinically until decades later.

  • Multi-system interactions: The health effects are not isolated to individual organs but interact synergistically. Metabolic disruption contributes to cardiovascular disease; reproductive dysfunction may involve both direct gonadal effects and metabolic contributions; neurodevelopmental effects may partly result from thyroid disruption.
  • Transgenerational consequences: The evidence of effects persisting across generations—where parental exposure affects unexposed offspring—suggests that bisphenol contamination may be establishing disease susceptibility in populations that extends beyond current exposure patterns.
  • Substitution failure: Across virtually every category of health risk, BPA analogues (BPS, BPF, BPAF, BPB) demonstrate comparable or superior toxicity. The "BPA-free" label provides no meaningful safety improvement, as the replacement chemicals exploit the same receptor pathways and produce the same spectrum of adverse effects.

This comprehensive health risk profile, rooted in the molecular mechanisms of endocrine disruption, establishes why bisphenols represent a significant public health concern and why regulatory approaches based on simple chemical substitution have failed to adequately protect human health.

References

  1. Cargnelutti, F., Di Nisio, A., Pallotti, F., Sabovic, I., Spaziani, M., Tarsitano, M. G., Paoli, D., & Foresta, C. (2021). Effects of endocrine disruptors on fetal testis development, male puberty, and transition age. Endocrine, 72, 358–374. https://doi.org/10.1007/s12020-020-02436-9
  2. Costa, H. E., & Cairrao, E. (2024). Effect of bisphenol A on the neurological system: A review update. Archives of Toxicology, 98, 1–73. https://doi.org/10.1007/s00204-023-03614-0
  3. Dalamaga, M., Kounatidis, D., Tsilingiris, D., Vallianou, N. G., Karampela, I., Psallida, S., & Papavassiliou, A. G. (2024). The role of endocrine disruptors bisphenols and phthalates in obesity: Current evidence, perspectives and controversies. International Journal of Molecular Sciences, 25, 675. https://doi.org/10.3390/ijms25010675
  4. Fonseca, M. I., Lorigo, M., & Cairrao, E. (2022). Endocrine-disrupting effects of bisphenol A on the cardiovascular system: A review. Journal of Xenobiotics, 12, 181–213. https://doi.org/10.3390/jox12030015
  5. Gałązka, A., & Jankiewicz, U. (2022). Endocrine disrupting compounds (nonylphenol and bisphenol A)–Sources, harmfulness and laccase-assisted degradation in the aquatic environment. Microorganisms, 10, 2236. https://doi.org/10.3390/microorganisms10112236
  6. Huang, Y., Zhang, W., Wang, R., Xiao, Z., Giesy, J. P., Wu, L., & Su, X. (2024). Multiplex analysis platform for evaluation of endocrine disruption of emerging contaminants against human steroid hormone receptors using autobioluminescent yeast bioassay: Application to bisphenols. Emerging Contaminants, 10, 100349. https://doi.org/10.1016/j.emcon.2024.100349
  7. Adegoke, E. O., Rahman, M. S., Amjad, S., Pang, W.-K., Ryu, D.-Y., Park, Y.-J., & Pang, M.-G. (2022). Bisphenol A damages testicular junctional proteins transgenerationally in mice. Environmental Pollution, 302, 119067. https://doi.org/10.1016/j.envpol.2022.119067
  8. Buoso, E., Masi, M., Limosani, R. V., Oliviero, C., Saeed, S., Iulini, M., Passoni, F. C., Racchi, M., & Corsini, E. (2025). Endocrine disrupting toxicity of bisphenol A and its analogs: Implications in the neuro-immune milieu. Journal of Xenobiotics, 15, 13. https://doi.org/10.3390/jox15010013
  9. Hall, J. M., & Greco, C. W. (2020). Perturbation of nuclear hormone receptors by endocrine disrupting chemicals: Mechanisms and pathological consequences of exposure. Cells, 9(1), 13. https://doi.org/10.3390/cells9010013
  10. Presunto, M., Mariana, M., Lorigo, M., & Cairrao, E. (2023). The effects of bisphenol A on human male infertility: A review of current epidemiological studies. International Journal of Molecular Sciences, 24, 12417. https://doi.org/10.3390/ijms241512417
  11. Stanojević, M., & Sollner Dolenc, M. (2025). Mechanisms of bisphenol A and its analogs as endocrine disruptors via nuclear receptors and related signaling pathways. Archives of Toxicology, 99, 2397–2417. https://doi.org/10.1007/s00204-025-04025-z
  12. Andonotopo, W., Bachnas, M. A., Dewantiningrum, J., Pramono, M. B. A., Akbar, M. I. A., Darmawan, E., Sanjaya, N. H., Aldiansyah, D., Sulistyowati, S., Stanojevic, M., & Kurjak, A. (2025). Endocrine disrupting chemicals: Translating mechanisms into perinatal risk assessment. Journal of Perinatal Medicine. Advance online publication. https://doi.org/10.1515/jpm-2025-0259
  13. Kek, T., Geršak, K., & Virant‑Klun, I. (2024). Exposure to endocrine disrupting chemicals (bisphenols, parabens, and triclosan) and their associations with preterm birth in humans. Reproductive Toxicology, 125, 108580. https://doi.org/10.1016/j.reprotox.2024.108580
  14. Land, K. L., Miller, F. G., Fugate, A. C., & Hannon, P. R. (2022). The effects of endocrine-disrupting chemicals on ovarian- and ovulation-related fertility outcomes. Molecular Reproduction and Development, 89(6), 608–631. https://doi.org/10.1002/mrd.23652
  15. Pathak, R. K., Jung, D.-W., Shin, S.-H., Ryu, B.-Y., Lee, H.-S., & Kim, J.-M. (2024). Deciphering the mechanisms and interactions of the endocrine disruptor bisphenol A and its analogs with the androgen receptor. Journal of Hazardous Materials, 469, https://doi.org/10.1016/j.jhazmat.2024.133935
  16. Peters, A. E., Ford, E. A., Roman, S. D., Bromfield, E. G., Nixon, B., Pringle, K. G., & Sutherland, J. M. (2024). Impact of bisphenol A and its alternatives on oocyte health: A scoping review. Human Reproduction Update, 30(6), 653–691. https://doi.org/10.1093/humupd/dmae025
  17. Ghosh, A., Tripathy, A., & Ghosh, D. (2022). Impact of endocrine disrupting chemicals (EDCs) on reproductive health of humans. Proceedings of the Zoological Society, 75(1), 16–30. https://doi.org/10.1007/s12595-021-00412-3
  18. Manzan-Martins, C., & Paulesu, L. (2021). Impact of bisphenol A (BPA) on cells and tissues at the human materno-fetal interface. Tissue and Cell, 73, 101662. https://doi.org/10.1016/j.tice.2021.101662
  19. Salami, E. A., & Rotimi, O. A. (2024). The impact of bisphenol-A on human reproductive health. Toxicology Reports, 13, 101773. https://doi.org/10.1016/j.toxrep.2024.101773
  20. Xue, S., Li, X., Zhou, S., Zhang, J., Sun, K., Peng, X., Chen, N., Dong, M., Jiang, T., Chen, Y., & Yan, W. (2024). Effects and mechanisms of endocrine disruptor bisphenol AF on male reproductive health: A mini review. Ecotoxicology and Environmental Safety, 276, https://doi.org/10.1016/j.ecoenv.2024.116300
  21. Biemann, R., Blüher, M., & Isermann, B. (2021). Exposure to endocrine-disrupting compounds such as phthalates and bisphenol A is associated with an increased risk for obesity. Best Practice & Research Clinical Endocrinology & Metabolism, 35, 101546. https://doi.org/10.1016/j.beem.2021.101546
  22. Guarnotta, V., Amodei, R., Frasca, F., Aversa, A., & Giordano, C. (2022). Impact of chemical endocrine disruptors and hormone modulators on the endocrine system. International Journal of Molecular Sciences, 23(10), 5710. https://doi.org/10.3390/ijms23105710
  23. Haverinen, E., Fernandez, M. F., Mustieles, V., & Tolonen, H. (2021). Metabolic syndrome and endocrine disrupting chemicals: An overview of exposure and health effects. International Journal of Environmental Research and Public Health, 18(24), 13047. https://doi.org/10.3390/ijerph182413047
  24. Cortes-Ramirez, S. A., Ho, S.-M., & Leung, Y.-K. (2024). Endocrine-disrupting chemicals: A looming threat to current and future generations. International Journal of Molecular Sciences, 25(15), 8222. https://doi.org/10.3390/ijms25158222
  25. Fu, X., Yana, R., Zhou, G., Chen, X., Liu, Y., Chi, J., Li, X., Fang, H., Li, H., & Li, W. (2022). New progress in photocatalytic degradation of bisphenol A as representative endocrine disrupting chemicals. Current Opinion in Green and Sustainable Chemistry, 35, 100629. https://doi.org/10.1016/j.cogsc.2022.100629
  26. Goralczyk, K. (2021). A review of the impact of selected anthropogenic chemicals from the group of endocrine disruptors on human health. Toxics, 9, 146. https://doi.org/10.3390/toxics9070146
  27. Trasande, L., & Sargis, R. M. (2024). Endocrine-disrupting chemicals: Mainstream recognition of health effects and implications for the practicing internist. Journal of Internal Medicine, 295(2), 259–274. https://doi.org/10.1111/joim.13748
  28. Palsania, P., Singhal, K., Dar, M. A., & Kaushik, G. (2024). Food grade plastics and Bisphenol A: Associated risks, toxicity, and bioremediation approaches. Journal of Hazardous Materials, 466, https://doi.org/10.1016/j.jhazmat.2024.133474
  29. Alsen, M., Sinclair, C., Cooke, P., Ziadkhanpour, K., Genden, E., & van Gerwen, M. (2021). Endocrine disrupting chemicals and thyroid cancer: An overview. Toxics, 9(1), 14. https://doi.org/10.3390/toxics9010014
  30. Di Pietro, G., Forcucci, F., & Chiarelli, F. (2023). Endocrine disruptor chemicals and children’s health. International Journal of Molecular Sciences, 24(3), 2671. https://doi.org/10.3390/ijms24032671
  31. Kawa, I. A., Masood, A., Fatima, Q., Mir, S. A., Jeelani, H., Manzoor, S., & Rashid, F. (2021). Endocrine disrupting chemical bisphenol A and its potential effects on female health. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 15, 803–811. https://doi.org/10.1016/j.dsx.2021.03.031
  32. Czarnywojtek, A., Jaz, K., Ochmańska, J., Zgorzalewicz-Stachowiak, M., Czarnocka, B., Sawicka-Gutaj, N., Ziółkowska, P., Krela-Kaźmierczak, I., Gut, P., Florek, E., & Ruchała, M. (2021). The effect of endocrine disruptors on the reproductive system – Current knowledge. European Review for Medical and Pharmacological Sciences, 25, 4930–4940.
  33. Seewoo, B. J., Wong, E. V. S., Mulders, Y. R., Gozt, A., Elagali, A., Symeonides, C., & Dunlop, S. A. (2024). A systematic evidence map protocol for mapping global exposure to bisphenols and their alternatives and social and environmental justice implications. Environment International, 194, 109091. https://doi.org/10.1016/j.envint.2024.109091
  34. Gonsioroski, A., Mourikes, V. E., & Flaws, J. A. (2020). Endocrine disruptors in water and their effects on the reproductive system. International Journal of Molecular Sciences, 21(6), 1929. https://doi.org/10.3390/ijms21061929
  35. Virant-Klun, I., Imamovic-Kumalic, S., & Pinter, B. (2022). From oxidative stress to male infertility: Review of the associations of endocrine-disrupting chemicals (bisphenols, phthalates, and parabens) with human semen quality. Antioxidants, 11, 1617. https://doi.org/10.3390/antiox11081617
  36. Ma, C.-X., Ma, X.-N., Li, H.-L., Mauricio, D., & Fu, S.-B. (2025). Endocrine-disrupting chemicals exposure: Cardiometabolic health risk in humans. Cardiovascular Diabetology, 24, 381. https://doi.org/10.1186/s12933-025-02938-8
  37. Rifa, R. A., & Lavado, R. (2024). Cytotoxic impacts of seven alternative bisphenols on human in vitro cellular models. Chemosphere, 366, 143408. https://doi.org/10.1016/j.chemosphere.2024.143408
  38. Stüfchen, I., Schweizer, J. R. O. L., Völter, F., Nowak, E., Braun, L., Kocabiyik, J., Mederos y Schnitzler, M., Williams, T. A., Kunz, S., Bidlingmaier, M., & Reincke, M. (2025). The impact of endocrine disrupting chemicals on adrenal corticosteroids – A systematic review of epidemiological studies. Environmental Research, 276, 121438. https://doi.org/10.1016/j.envres.2025.121438
  39. Farounbi, A. I., & Ngqwala, N. P. (2020). Occurrence of selected endocrine disrupting compounds in the Eastern Cape Province of South Africa. Environmental Science and Pollution Research, 27, 17268–17279. https://doi.org/10.1007/s11356-020-08082-y
  40. Palacios-Arreola, M. I., Moreno-Mendoza, N. A., Nava-Castro, K. E., Segovia-Mendoza, M., Perez-Torres, A., Garay-Canales, C. A., & Morales-Montor, J. (2022). The endocrine disruptor compound bisphenol-A (BPA) regulates the intra-tumoral immune microenvironment and increases lung metastasis in an experimental model of breast cancer. International Journal of Molecular Sciences, 23, 2523. https://doi.org/10.3390/ijms23052523
  41. Zhang, X., Flaws, J. A., Spinella, M. J., & Irudayaraj, J. (2023). The relationship between typical environmental endocrine disruptors and kidney disease. Toxics, 11, https://doi.org/10.3390/toxics11010032
  42. Tsai, W.-T. (2023). Survey on the environmental risks of bisphenol A and its relevant regulations in Taiwan: An environmental endocrine-disrupting chemical of increasing concern. Toxics, 11, 722. https://doi.org/10.3390/toxics11090722